Epstein-barr Virus-associated Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-10-21
Clinical Trial Update: Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies [Phase 2]
Phase 2 clinical trial update of VK 2019, a novel EBNA1 inhibitor, in EBV-positive nasopharyngeal carcinoma and other EBV-associated cancers…